We used a panel of SCLC cell lines with exclusive MYC paralog amplification and two SCLC cell lines without MYC paralog amplification or overexpression to assess the anti-tumor effects of JQ1 and BMN673 (Supplementary Table 6). The gene discussed is MYC; the disease is small cell lung carcinoma.